IDEAYA Biosciences (IDYA) EPS (Basic) (2018 - 2026)
IDEAYA Biosciences (IDYA) posted EPS (Basic) of -$2.62 for Q1 2026, down 146.88% sequentially from -$1.06 in Q4 2025, and down 148.95% YoY from $5.36 in Q1 2025.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) EPS (Basic) (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has reported EPS (Basic) for 9 years, with the latest figure at -$2.62 in Q1 2026.
- Quarterly EPS (Basic) fell 148.95% year-over-year to -$2.62 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.87 (up 19.71% YoY) and the FY2025 annual result came in at -$4.0, up 33.48% from the prior year.
- EPS (Basic) slipped to -$2.62 in Q1 2026 per IDYA's latest filing, from -$1.06 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.34 in Q3 2025 and troughed at -$2.62 in Q1 2026.
- A 5-year average of -$1.01 and a median of -$0.71 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) tumbled 245.86% in 2024, then soared 121.86% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.61 in 2022, then decreased by 11.45% to -$0.68 in 2023, then plunged by 164.55% to -$1.8 in 2024, then jumped by 41.0% to -$1.06 in 2025, then tumbled by 146.88% to -$2.62 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$2.62, -$1.06, and $0.34 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | IDEAYA Biosciences | 3.66 Bn | 2.83 Bn | - | -1.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.34 |
| Mar 31, 2026 | -1.25 |
| Dec 31, 2025 | -1.07 |
| Sep 30, 2025 | 1.23 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -0.95 |
| Dec 31, 2024 | -1.80 |
| Sep 30, 2024 | -0.72 |
| Jun 30, 2024 | -0.84 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -0.71 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.58 |
| Mar 31, 2023 | -0.51 |
| Dec 31, 2022 | -0.61 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | -0.60 |
| Mar 31, 2022 | -0.42 |
| Dec 31, 2021 | -0.54 |
| Sep 30, 2021 | -0.31 |